Norton Healthcare & Select Medical tie up on outpatient rehabilitation
Category: #health  By Nikita Chaurasia  Date: 2019-05-02
  • share
  • Twitter
  • Facebook
  • LinkedIn

Norton Healthcare & Select Medical tie up on outpatient rehabilitation

In a recent turn of events, Norton Healthcare and Select Medical have reportedly declared signing a joint venture agreement intended to assimilate outpatient rehabilitation solutions in the Southern Indiana and Louisville metro provinces. 

As per the terms of the contract, Norton Healthcare donated its 3 centers and Select Medical donated twenty-nine of its KORT (Kentucky Orthopedic Rehab Team) centers to the venture.

According to David Chernow, Chief Executive Officer and President of Select Medical, the Norton Healthcare and organization’s KORT network have had a mutual mission to offer exceptional patient care. He further stated that this joint venture agreement enables the two organizations to further integrate advanced rehabilitative care and finest practices to offer the best possible patient results. 

For the record, Kentucky Orthopedic Rehab Team, which is a fully owned business unit of Select Medical, carries expertise in hand therapy, work health, physical therapy, and sports medicine.

Steven T. Hester, M.D., MBA, System Chief Medical Officer and Division President of Provider Operations, Norton Healthcare, reportedly stated that the organization has enjoyed a long term relationship with Kentucky Orthopedic Rehab Team and Select Medical which has served patients tremendously well.

Hester further mentioned that this joint venture solemnizes the outstanding work we perform together to aid our patients' recovery throughout the full gamut of care.

With over sixty-three locations across southern Indiana and Kentucky, KORT has the biggest team of board-qualified occupational therapists, physical therapists, and qualified athletic coaches in the Kentuckiana region.  

For the uninitiated, Select Medical has the largest number of rehabilitation hospitals, critical illness recovery hospitals, occupational health centers, and outpatient rehabilitation clinics in the United States. Moreover, Concentra, Select Medical's joint venture subsidiary, runs approximately 525 occupational health centers in over 40 states, along with offering contract services at employer locations & Department of Veterans Affairs outpatient clinics.

SourceCredits:https://www.prnewswire.com/news-releases/select-medical-and-norton-healthcare-sign-joint-venture-agreement-to-integrate-outpatient-rehabilitative-services-in-kentucky-and-indiana-300841670.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Tmunity doses first patient in Phase 1 CART-TnMUC1 clinical trial
Tmunity doses first patient in Phase 1 CART-TnMUC1 clinical trial
By Nikita Chaurasia

Tmunity Therapeutics Inc., a clinical-stage biotherapeutics firm focused on advanced T-cell immunotherapy, has reportedly dosed the first patient in its Phase 1 CART-TnMUC1-01 clinical trial with TnMUC1 (Tn/STn glycoform of mucin 1) CAR-T (chimeric a...

Hyundai and Uber team up to develop all-electric flying taxis
Hyundai and Uber team up to develop all-electric flying taxis
By Nikita Chaurasia

In the midst of technological advancements increasing at a commendable pace, Uber’s flying taxi initiative seems to be edging closer to reality – the reality of establishing flying cars in the near future. The ride-hailing giant has appar...

BioXcel begins Phase 3 BXCL501 trial for treating SCZ & bipolar disorder
BioXcel begins Phase 3 BXCL501 trial for treating SCZ & bipolar disorder
By Nikita Chaurasia

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical firm leveraging artificial intelligence approaches to advance the next wave of medicines in immuno-oncology and neuroscience, has reportedly announced the initiation of its SERENITY progr...